Download PDF
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Clinical and Lung Microbiome Impact of Chronic Versus Intermittent Pseudomonas aeruginosa Infection in Bronchiectasis
Laia Fernández-Barat; Ruben López-Aladid; Victoria Alcaraz-Serrano; Nil Vázquez; Leticia Bueno-Freire; Roque Pastor-Ibañez; Lena Lingren; Héctor Sanz-Fraile; Patricia Oscanoa; Ana Motos; Roberto Cabrera; Jordi Vila; Daniel Martínez; Jordi Otero; Ramon Farré; Niels Høiby; Antoni Torres;
Arch Bronconeumol. 2025;61:669-79
High Adherence, Microbiological Control and Reduced Exacerbations in Patients With Non-Cystic Fibrosis Bronchiectasis Treated With Nebulised Colistin. A Prospective Observational Study
Belén Navas-Bueno; Francisco Casas-Maldonado; Alicia Padilla-Galo; Enrique González-Moya-Mondelo; Manuel Arenas-Gordillo; Juan Carlos Bioque-Rivera; Rocío Jimeno- Galván; Maria Soledad Cano-Gómez; Jose Luis López-Campos; Silvia Merlos-Navarro; Agustín Valido-Morales; Jose Manuel Vaquero-Barrios;
Arch Bronconeumol. 2022;58:834-6
C-Reactive Protein Concentration in Steady-State Bronchiectasis: Prognostic Value of Future Severe Exacerbations. Data From the Spanish Registry of Bronchiectasis (RIBRON)
Tomás Posadas; Grace Oscullo; Enrique Zaldivar; Carmen Villa; Yadira Dobarganes; Rosa Girón; Casilda Olveira; Luis Maíz; Marta García-Clemente; Oriol Sibila; Rafael Golpe; Juan Rodríguez; Esther Barreiro; Juan Luis Rodriguez; Rosario Menéndez; Concepción Prados; David de la Rosa; Miguel Angel Martinez-García;
Arch Bronconeumol. 2021;57:21-7